Literature DB >> 29369708

Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis.

Michael Y Henein1, Ole B Suhr1, Sandra Arvidsson2, Björn Pilebro1, Per Westermark3, Rolf Hörnsten2, Per Lindqvist1.   

Abstract

BACKGROUND: Cardiac amyloidosis (CA) is a myocardial disease and commonly under-diagnosed condition. In CA patients, atrial fibrillation might occur in the absence of left atrial (LA) enlargement.
OBJECTIVES: The aim of this study is to assess LA size and function, and its relationship with atrial arrhythmia in patients with hereditary transthyretin amyloidosis (ATTR).
METHODS: Forty-six patients with confirmed ATTR amyloidosis on abdominal biopsy were studied. Assessment with 2D echocardiography and 2D strain showed 31 patients had increased LV wall thickness (LVWT) (septal thickness >12 mm), and 15 had normal LVWT. In addition to conventional measurements, LV and LA global longitudinal strain (GLS%) and strain rate (SR) were obtained. Western blot analysis was done to assess fibril type. ATTR patients with increased LVWT were compared with 23 patients with hypertrophic cardiomyopathy (HCM) and 31 healthy controls. ATTR amyloidosis patients also underwent 24 hour Holter monitoring to determine the presence of atrial arrhythmia.
RESULTS: Atrial deformation during atrial systole was reduced in ATTR amyloidosis patients with increased LVWT independent of LA size and in contrast to HCM. Twenty of the ATTR amyloidosis patients (54%) had ECG evidence of significant atrial arrhythmic events. LA strain rate, during atrial systole, was the only independent predictor of atrial arrhythmia (β = 3.28, p = .012).
CONCLUSION: In ATTR cardiomyopathy with increased LVWT, LA myocardial function is abnormal, irrespective of atrial cavity size. Reduced LA myocardial SR during atrial systole, irrespective of cavity volume, E/e' and LV deformation, is also a strong predictor for atrial arrhythmic events.

Entities:  

Keywords:  Arrhythmia; Holter ECG; deformation echocardiography; left atrial function

Mesh:

Year:  2018        PMID: 29369708     DOI: 10.1080/13506129.2018.1430027

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  13 in total

1.  Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Koichiro Kuwahara; Tsutomu Katsuyama; Kazutoshi Maruyama
Journal:  J Echocardiogr       Date:  2019-02-11

Review 2.  Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.

Authors:  Angelos G Rigopoulos; Muhammad Ali; Elena Abate; Abdel-Rahman Torky; Marios Matiakis; Mammad Mammadov; Hannes Melnyk; Alexander Vogt; Renato de Vecchis; Boris Bigalke; Walter Wohlgemuth; Sophie Mavrogeni; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

3.  Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates.

Authors:  Giovanni Donato Aquaro; Sofia Morini; Chrysanthos Grigoratos; Giulia Taborchi; Gianluca Di Bella; Raffaele Martone; Elisa Vignini; Michele Emdin; Iacopo Olivotto; Federico Perfetto; Francesco Cappelli
Journal:  Int J Cardiol Heart Vasc       Date:  2020-09-14

4.  Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy: A Systematic Review.

Authors:  Pranav Chandrashekar; Laith Alhuneafat; Meghan Mannello; Lana Al-Rashdan; Morris M Kim; Jason Dungu; Kevin Alexander; Ahmad Masri
Journal:  Circ Genom Precis Med       Date:  2021-08-31

5.  Trends, burden, and impact of arrhythmia on cardiac amyloid patients: A 16-year nationwide study from 1999 to 2014.

Authors:  Ameesh Isath; Ashish Correa; Gregory P Siroky; Stuthi Perimbeti; Selma Mohammed; C Anwar A Chahal; Deepak Padmanabhan; Davendra Mehta
Journal:  J Arrhythm       Date:  2020-06-11

Review 6.  How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage.

Authors:  Yasuhiro Izumiya; Hiroya Hayashi; Hirotoshi Ishikawa; Atsushi Shibata; Minoru Yoshiyama
Journal:  Intern Med       Date:  2020-07-21       Impact factor: 1.271

7.  Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study.

Authors:  Cassady Palmer; Vien T Truong; Jeremy A Slivnick; Sarah Wolking; Paige Coleman; Wojciech Mazur; Karolina M Zareba
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

Review 8.  Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.

Authors:  Yiu Ming Khor; Sarah Cuddy; Rodney H Falk; Sharmila Dorbala
Journal:  Semin Nucl Med       Date:  2020-02-09       Impact factor: 4.802

9.  Epigenetic profiling of Italian patients identified methylation sites associated with hereditary transthyretin amyloidosis.

Authors:  Antonella De Lillo; Gita A Pathak; Flavio De Angelis; Marco Di Girolamo; Marco Luigetti; Mario Sabatelli; Federico Perfetto; Sabrina Frusconi; Dario Manfellotto; Maria Fuciarelli; Renato Polimanti
Journal:  Clin Epigenetics       Date:  2020-11-17       Impact factor: 6.551

10.  Left atrial structural and mechanical remodelling in heart failure with reduced ejection fraction.

Authors:  Andrea Rossi; Erberto Carluccio; Matteo Cameli; Riccardo M Inciardi; Giulia Elena Mandoli; Andreina D'Agostino; Paolo Biagioli; Caterina Maffeis; Nicola R Pugliese; Maria Concetta Pastore; Anna Mengoni; Roberto Pedrinelli; Michael Henein; Frank L Dini
Journal:  ESC Heart Fail       Date:  2021-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.